MC-LBB-004 LEUKOCYTE-REDUCED PLATELET PHERESIS.pdf
MC-LBB-011 INCREASE DEMAND OF BLOOD SUPPLY.pdf
MC-LBB-013 SEROLOGIC TESTS REQUIRED ON DONATED BLOOD PRODUCTS A.pdf
MC-LBB-025 ANTIBODY IDENTIFICATION GUIDELINES.pdf
MC-LBB-028 KLEIHAUER-BETKE TEST.pdf
MC-LBB-044 GUIDELINES FOR BLOOD COMPONENT RANSFUSION AND BLOOD.pdf
MC-LBB-045 GUIDELINES FOR BLOOD COMPONENTS TRANSFUSION IN NEONA.pdf
MC-LBB-046 GENERAL GUIDELINES FOR DEALING WITH MASSIVE TRANSFUS.pdf
MC-LBB-047 MAXIMUM SURGICAL BLOOD ORDERING SCHEDULE.pdf
MC-LBB-049 RESOLVING CROSSMATCH INCOMPATIBILITIES.pdf
MC-LBB-051 SELECTION OF BLOOD FOR EXCHANGE TRANSFUSION.pdf
MC-LBB-052 ISSUING BLOOD PRODUCT FOR A PATIENT ADMITTED.pdf
MC-LBB-053 GUIDELINES FOR TRANSFUSING PATIENTS WITH AUTOANTIBODIES AND AUTOIMMUNE HEMOLYTIC ANEMIA.pdf
MC-LBB-055 BLOOD BANK REQUISITION FORMS.pdf
MC-LBB-058 QUALITY ASSURANCE IN BLOOD BANK.pdf
MC-LBB-063 VISUAL INSPECTION OF LOOD AND BLOOD COMPONENTS .pdf
MC-LBB-078 COMPATIBILITY TESTING.pdf
MC-LBB-079 TRANSPORTATION OF BLOOD AND BLOOD COMPONENTS.pdf
MC-LBB-080 IRRADIATION OF BLOOD PRODUCTS .pdf
MC-LBB-081 INVESTIGATION OF SUSPECTED CASES OF POST-TRANSFUSION .pdf
MC-LBB-082 SELECTION OF BLOOD AND BLOOD COMPONENTS FOR P.pdf
MC-LBB-083 PERINATAL TESTING.pdf
MC-LBB-084 CONTROL OF ISSUANCE AND RELEASE OF BLOOD COMPONENTS.pdf
